188 related articles for article (PubMed ID: 16276512)
21. Expression of the tumour necrosis factor receptor-associated factors 1 and 2 in Hodgkin's disease.
Murray PG; Flavell JR; Baumforth KR; Toomey SM; Lowe D; Crocker J; Ambinder RF; Young LS
J Pathol; 2001 Jun; 194(2):158-64. PubMed ID: 11400143
[TBL] [Abstract][Full Text] [Related]
22. Childhood Hodgkin's disease in the United States: an analysis of histologic subtypes and association with Epstein-Barr virus.
Andriko JA; Aguilera NS; Nandedkar MA; Abbondanzo SL
Mod Pathol; 1997 Apr; 10(4):366-71. PubMed ID: 9110300
[TBL] [Abstract][Full Text] [Related]
23. Expression of heat shock protein 70 (HSP70) and EBV latent membrane protein 1 (LMP1) in Reed-Sternberg cells of Hodgkin's disease.
Takahashi H; Fujita S; Shibata Y; Tsuda N; Okabe H
Anal Cell Pathol; 1996 Nov; 12(2):71-83. PubMed ID: 8986292
[TBL] [Abstract][Full Text] [Related]
24. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma.
Gulley ML; Glaser SL; Craig FE; Borowitz M; Mann RB; Shema SJ; Ambinder RF
Am J Clin Pathol; 2002 Feb; 117(2):259-67. PubMed ID: 11863222
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus in Hodgkin's disease.
Herbst H
Semin Cancer Biol; 1996 Aug; 7(4):183-9. PubMed ID: 8946602
[TBL] [Abstract][Full Text] [Related]
26. Study of association of Epstein Barr-virus with Hodgkin's disease.
Radha K; Shanthi P; Madhavan M; Senthamarai A
Indian J Pathol Microbiol; 1997 Jul; 40(3):351-4. PubMed ID: 9354006
[TBL] [Abstract][Full Text] [Related]
27. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus and other candidate viruses in the pathogenesis of Hodgkin's disease.
Jarrett RF; MacKenzie J
Semin Hematol; 1999 Jul; 36(3):260-9. PubMed ID: 10462326
[TBL] [Abstract][Full Text] [Related]
29. Antigen presenting phenotype of Hodgkin Reed-Sternberg cells: analysis of the HLA class I processing pathway and the effects of interleukin-10 on epstein-barr virus-specific cytotoxic T-cell recognition.
Lee SP; Constandinou CM; Thomas WA; Croom-Carter D; Blake NW; Murray PG; Crocker J; Rickinson AB
Blood; 1998 Aug; 92(3):1020-30. PubMed ID: 9680372
[TBL] [Abstract][Full Text] [Related]
30. Structural variability of the carboxy-terminus of Epstein-Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas.
Guiretti DM; Chabay PA; Valva P; Stefanoff CG; Barros MH; De Matteo E; Renault IZ; Preciado MV; Hassan R
J Med Virol; 2007 Nov; 79(11):1730-22. PubMed ID: 17854036
[TBL] [Abstract][Full Text] [Related]
31. Morphologic differences between latent membrane protein-1 (LMP-1)-positive and negative tumour cells in Epstein-Barr virus (EBV)-related childhood Hodgkin's disease. A morphometric study.
Panayiotides J; Kanavaros P; Protopapa E; Vlachonikolis J; Tzardi M; Kalmanti M; Delides G
Pathol Res Pract; 1996 Mar; 192(3):210-4. PubMed ID: 8739467
[TBL] [Abstract][Full Text] [Related]
32. Isolation and analysis of two strongly transforming isoforms of the Epstein-Barr-Virus(EBV)-encoded latent membrane protein-1 (LMP1) from a single Hodgkin's lymphoma.
Mehl AM; Fischer N; Rowe M; Hartmann F; Daus H; Trümper L; Pfreundschuh M; Müller-Lantzsch N; Grässer FA
Int J Cancer; 1998 Apr; 76(2):194-200. PubMed ID: 9537580
[TBL] [Abstract][Full Text] [Related]
33. Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease.
Beck A; Päzolt D; Grabenbauer GG; Nicholls JM; Herbst H; Young LS; Niedobitek G
J Pathol; 2001 Jun; 194(2):145-51. PubMed ID: 11400141
[TBL] [Abstract][Full Text] [Related]
34. In Hodgkin's disease Reed-Sternberg cells and normal B-lymphocytes are infected by related Epstein-Barr virus strains.
Faumont N; Trempat P; Brousset P; Delsol G; Meggetto F
Virus Res; 2004 May; 101(2):163-73. PubMed ID: 15041184
[TBL] [Abstract][Full Text] [Related]
35. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus in Hodgkin's disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection.
Sleckman BG; Mauch PM; Ambinder RF; Mann R; Pinkus GS; Kadin ME; Sherburne B; Perez-Atayde A; Thior I; Mueller N
Cancer Epidemiol Biomarkers Prev; 1998 Dec; 7(12):1117-21. PubMed ID: 9865430
[TBL] [Abstract][Full Text] [Related]
37. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes.
Khanna R; Burrows SR; Nicholls J; Poulsen LM
Eur J Immunol; 1998 Feb; 28(2):451-8. PubMed ID: 9521052
[TBL] [Abstract][Full Text] [Related]
38. Expression of human tumor-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: a potential mechanism of immune evasion.
Ohshima K; Muta K; Nakashima M; Haraoka S; Tutiya T; Suzumiya J; Kawasaki C; Watanabe T; Kikuchi M
Int J Cancer; 2001 Jul; 93(1):91-6. PubMed ID: 11391627
[TBL] [Abstract][Full Text] [Related]
39. Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma.
Claviez A; Tiemann M; Lüders H; Krams M; Parwaresch R; Schellong G; Dörffel W
J Clin Oncol; 2005 Jun; 23(18):4048-56. PubMed ID: 15961758
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus and Hodgkin's lymphoma.
Andersson J
Herpes; 2006 May; 13(1):12-6. PubMed ID: 16732997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
